Semaglutide GMP DMF Grade:High-Purity Raw Material for Anti-Diabetic & Weight Loss Products

description1
Product Description
Semaglutide GMP DMF grade is a highpurity peptide product developed for pharmaceutical applications. It exhibits strong GLP1 receptor agonist activity, leading to glucosedependent insulin secretion, suppressed glucagon release, delayed gastric emptying, and reduced appetite. With excellent stability and batchtobatch consistency, it is a reliable active ingredient for the production of diabetes and obesity therapeutics..
Attributes
| English Name | Semaglutide (GMP DMF Grade) | Endotoxin | < 1.0 EU/mg (where specified) |
| CAS NO | 910463-68-2 | Sterility | Sterile filtered (as per manufacturing specification) |
| Molecular Formula | C₁₈₇H₂₉₁N₄₅O₅₉ | Storage Condition | Store at –20°C or below, protected from light, in a dry sealed container |
| Mol.wt. | ≈ 4114 Da | Solubility | Soluble in water and dilute aqueous buffers |
| EINECS No. | Not applicable (biological peptide) | Form | Powder |
| MDL No. | / | Colour | White to offwhite lyophilized powder |
| DMF Status | Active Drug Master File available for regulatory reference | Purity (HPLC) | ≥ 99.0% |
Effective Glycemic Control
Promotes glucosedependent insulin secretion and suppresses inappropriate glucagon release, significantly lowering HbA1c in patients with type 2 diabetes.
Sustained Weight Management
Reduces appetite and delays gastric emptying, leading to clinically meaningful and durable weight loss.
Cardiovascular Risk Reduction
Demonstrated cardiovascular outcome benefits in highrisk patients, including reduced risk of major adverse cardiovascular events.
Modulates inflammation and oxidative stress, which contribute to vascular damage.
01
The field of pharmaceutical raw materials
Research and development of drugs for the treatment of type 2 diabetes
Production of drugs for obesity treatment.
Cardiovascular protective adjuvant drugs.
01
In the field of health supplements/functional foods
Metabolic health maintenance products
Weight management function products
03
Cross-border pharmaceutical trade scenarios
Multi-dosage form compatibility: Compatible with the research and development of various dosage forms such as injections, oral tablets, capsules, and sustained-release microspheres.
0102030405060708

About Us
Shaanxi Bieyouth Biotech Co., Ltd. is proud to offer Semaglutide, a cutting-edge supplement for those seeking to enhance their cellular health and protect against the ravages of time. By incorporating our Semaglutide into your health regimen, you are taking a proactive step towards safeguarding your body's cells and promoting a longer, healthier life. Experience the power of this elite antioxidant and embrace the benefits of Semaglutide for your well-being.






Whatsapp
WeChat